nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—F2—atherosclerosis	0.622	1	CbGaD
Ximelagatran—CYP2C9—Rosuvastatin—atherosclerosis	0.0541	0.267	CbGbCtD
Ximelagatran—CYP2C9—Simvastatin—atherosclerosis	0.0503	0.248	CbGbCtD
Ximelagatran—CYP2C9—Pravastatin—atherosclerosis	0.0492	0.243	CbGbCtD
Ximelagatran—CYP2C9—Lovastatin—atherosclerosis	0.0492	0.243	CbGbCtD
Ximelagatran—F2—vein—atherosclerosis	0.0138	0.221	CbGeAlD
Ximelagatran—F2—leg—atherosclerosis	0.0102	0.164	CbGeAlD
Ximelagatran—F2—hindlimb—atherosclerosis	0.00915	0.147	CbGeAlD
Ximelagatran—F2—appendage—atherosclerosis	0.00785	0.126	CbGeAlD
Ximelagatran—F2—artery—atherosclerosis	0.00561	0.0899	CbGeAlD
Ximelagatran—F2—endothelium—atherosclerosis	0.00474	0.0759	CbGeAlD
Ximelagatran—F2—blood vessel—atherosclerosis	0.00437	0.07	CbGeAlD
Ximelagatran—F2—connective tissue—atherosclerosis	0.00224	0.0359	CbGeAlD
Ximelagatran—F2—cardiovascular system—atherosclerosis	0.00195	0.0312	CbGeAlD
Ximelagatran—F2—liver—atherosclerosis	0.0012	0.0193	CbGeAlD
Ximelagatran—CYP2C9—cardiovascular system—atherosclerosis	0.000776	0.0124	CbGeAlD
Ximelagatran—CYP2C9—liver—atherosclerosis	0.00048	0.0077	CbGeAlD
Ximelagatran—F2—Folate Metabolism—IL6—atherosclerosis	9.7e-05	0.000863	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—TNF—atherosclerosis	9.55e-05	0.000849	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—F7—atherosclerosis	9.5e-05	0.000845	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—GHRL—atherosclerosis	9.47e-05	0.000842	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CCL2—atherosclerosis	9.37e-05	0.000834	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—HSPD1—atherosclerosis	9.27e-05	0.000825	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	9.19e-05	0.000818	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	9.12e-05	0.000812	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	8.92e-05	0.000793	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAT—atherosclerosis	8.46e-05	0.000753	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—KNG1—atherosclerosis	8.31e-05	0.000739	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—AGTR1—atherosclerosis	8.26e-05	0.000735	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	8.16e-05	0.000726	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL4—atherosclerosis	8.07e-05	0.000718	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—UTS2—atherosclerosis	7.92e-05	0.000705	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	7.75e-05	0.00069	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—ALB—atherosclerosis	7.74e-05	0.000688	CbGpPWpGaD
Ximelagatran—F2—Selenium Micronutrient Network—IL6—atherosclerosis	7.7e-05	0.000685	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	7.63e-05	0.000679	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CASR—atherosclerosis	7.59e-05	0.000676	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	7.59e-05	0.000675	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—F7—atherosclerosis	7.47e-05	0.000665	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KNG1—atherosclerosis	7.43e-05	0.000661	CbGpPWpGaD
Ximelagatran—F2—Peptide ligand-binding receptors—CXCL8—atherosclerosis	7.41e-05	0.000659	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAUR—atherosclerosis	7.36e-05	0.000655	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—atherosclerosis	7.22e-05	0.000642	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLG—atherosclerosis	7.2e-05	0.00064	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—UTS2—atherosclerosis	7.19e-05	0.00064	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	7.13e-05	0.000635	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR2—atherosclerosis	7.06e-05	0.000628	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—EDN1—atherosclerosis	7e-05	0.000623	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL5—atherosclerosis	6.95e-05	0.000618	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	6.91e-05	0.000615	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SOD1—atherosclerosis	6.9e-05	0.000614	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CX3CR1—atherosclerosis	6.89e-05	0.000613	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CASR—atherosclerosis	6.89e-05	0.000613	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CX3CL1—atherosclerosis	6.76e-05	0.000602	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—GHRL—atherosclerosis	6.66e-05	0.000592	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRH1—atherosclerosis	6.59e-05	0.000587	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF2—atherosclerosis	6.55e-05	0.000583	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—ACE—atherosclerosis	6.45e-05	0.000574	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR2—atherosclerosis	6.41e-05	0.00057	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—APOB—atherosclerosis	6.36e-05	0.000566	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	6.29e-05	0.000559	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	6.18e-05	0.00055	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	6.18e-05	0.00055	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PRKCG—atherosclerosis	5.91e-05	0.000526	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—AGT—atherosclerosis	5.81e-05	0.000517	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PLAUR—atherosclerosis	5.79e-05	0.000515	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CD36—atherosclerosis	5.77e-05	0.000514	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PLG—atherosclerosis	5.66e-05	0.000504	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL3—atherosclerosis	5.51e-05	0.00049	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR2—atherosclerosis	5.49e-05	0.000488	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—EDNRA—atherosclerosis	5.49e-05	0.000488	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GHRL—atherosclerosis	5.35e-05	0.000476	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	5.33e-05	0.000474	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PDGFB—atherosclerosis	5.32e-05	0.000474	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MMP1—atherosclerosis	5.26e-05	0.000468	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOA4—atherosclerosis	5.17e-05	0.00046	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	5.16e-05	0.000459	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF2—atherosclerosis	5.16e-05	0.000459	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CAV1—atherosclerosis	5.05e-05	0.000449	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	5.04e-05	0.000449	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—APOA1—atherosclerosis	5.03e-05	0.000448	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR2—atherosclerosis	4.98e-05	0.000444	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDNRA—atherosclerosis	4.98e-05	0.000444	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.97e-05	0.000442	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	4.89e-05	0.000435	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	4.89e-05	0.000435	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GHRL—atherosclerosis	4.86e-05	0.000432	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL2—atherosclerosis	4.79e-05	0.000426	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL4—atherosclerosis	4.77e-05	0.000424	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	4.77e-05	0.000424	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS2—atherosclerosis	4.75e-05	0.000422	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	4.7e-05	0.000418	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—KNG1—atherosclerosis	4.7e-05	0.000418	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AGTR1—atherosclerosis	4.67e-05	0.000415	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	4.6e-05	0.000409	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	4.6e-05	0.000409	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CG—atherosclerosis	4.6e-05	0.000409	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	4.51e-05	0.000401	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOA2—atherosclerosis	4.45e-05	0.000396	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	4.43e-05	0.000394	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KNG1—atherosclerosis	4.26e-05	0.000379	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—UTS2—atherosclerosis	4.25e-05	0.000378	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AGTR1—atherosclerosis	4.24e-05	0.000377	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IGF1—atherosclerosis	4.21e-05	0.000374	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP1—atherosclerosis	4.14e-05	0.000368	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.1e-05	0.000365	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—AGT—atherosclerosis	4.09e-05	0.000364	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CX3CR1—atherosclerosis	4.07e-05	0.000362	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASR—atherosclerosis	4.07e-05	0.000362	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—LEP—atherosclerosis	4.01e-05	0.000356	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SERPINE1—atherosclerosis	4e-05	0.000356	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CX3CL1—atherosclerosis	3.99e-05	0.000355	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—atherosclerosis	3.99e-05	0.000355	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—EDN1—atherosclerosis	3.96e-05	0.000352	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCL5—atherosclerosis	3.93e-05	0.000349	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.88e-05	0.000346	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.88e-05	0.000346	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.88e-05	0.000346	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.88e-05	0.000346	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.84e-05	0.000341	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS3—atherosclerosis	3.81e-05	0.000339	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR2—atherosclerosis	3.79e-05	0.000337	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—atherosclerosis	3.78e-05	0.000337	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MMP3—atherosclerosis	3.78e-05	0.000336	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	3.77e-05	0.000335	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PRKCG—atherosclerosis	3.73e-05	0.000332	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.71e-05	0.00033	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EDN1—atherosclerosis	3.59e-05	0.00032	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL5—atherosclerosis	3.57e-05	0.000317	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.55e-05	0.000316	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—INS—atherosclerosis	3.42e-05	0.000304	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.42e-05	0.000304	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	3.4e-05	0.000303	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PRKCG—atherosclerosis	3.39e-05	0.000302	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	3.38e-05	0.000301	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VWF—atherosclerosis	3.37e-05	0.0003	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCL2—atherosclerosis	3.37e-05	0.0003	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOC3—atherosclerosis	3.35e-05	0.000298	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LDLR—atherosclerosis	3.33e-05	0.000297	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—IGF1—atherosclerosis	3.31e-05	0.000295	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.3e-05	0.000294	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AGT—atherosclerosis	3.28e-05	0.000292	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL3—atherosclerosis	3.26e-05	0.00029	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—atherosclerosis	3.2e-05	0.000285	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLTP—atherosclerosis	3.18e-05	0.000283	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NCF1—atherosclerosis	3.12e-05	0.000277	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AGT—atherosclerosis	2.98e-05	0.000265	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDNRA—atherosclerosis	2.94e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR2—atherosclerosis	2.94e-05	0.000262	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.94e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CYBA—atherosclerosis	2.93e-05	0.000261	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.93e-05	0.00026	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.91e-05	0.000259	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.9e-05	0.000258	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GHRL—atherosclerosis	2.87e-05	0.000255	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PARP1—atherosclerosis	2.87e-05	0.000255	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLAT—atherosclerosis	2.87e-05	0.000255	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.84e-05	0.000253	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.75e-05	0.000245	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.75e-05	0.000245	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—atherosclerosis	2.75e-05	0.000245	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.72e-05	0.000242	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—atherosclerosis	2.66e-05	0.000237	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—atherosclerosis	2.64e-05	0.000235	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK3—atherosclerosis	2.6e-05	0.000231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.57e-05	0.000229	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TGFB1—atherosclerosis	2.52e-05	0.000224	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KNG1—atherosclerosis	2.52e-05	0.000224	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGTR1—atherosclerosis	2.5e-05	0.000223	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL2—atherosclerosis	2.46e-05	0.000219	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLG—atherosclerosis	2.44e-05	0.000217	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SOCS3—atherosclerosis	2.31e-05	0.000206	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.29e-05	0.000204	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP3—atherosclerosis	2.23e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF2—atherosclerosis	2.22e-05	0.000198	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.18e-05	0.000194	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOB—atherosclerosis	2.16e-05	0.000192	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—atherosclerosis	2.14e-05	0.00019	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EDN1—atherosclerosis	2.12e-05	0.000189	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL5—atherosclerosis	2.11e-05	0.000187	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LPL—atherosclerosis	2.06e-05	0.000183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LCAT—atherosclerosis	2.05e-05	0.000182	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FABP4—atherosclerosis	2.05e-05	0.000182	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA4—atherosclerosis	2.01e-05	0.000179	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCG—atherosclerosis	2e-05	0.000178	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.97e-05	0.000176	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SPP1—atherosclerosis	1.95e-05	0.000174	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—atherosclerosis	1.94e-05	0.000173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.88e-05	0.000167	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.82e-05	0.000162	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDGFB—atherosclerosis	1.8e-05	0.000161	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.8e-05	0.00016	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGT—atherosclerosis	1.76e-05	0.000157	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—atherosclerosis	1.75e-05	0.000156	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.75e-05	0.000156	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA2—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—LEP—atherosclerosis	1.73e-05	0.000154	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CAV1—atherosclerosis	1.71e-05	0.000152	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.71e-05	0.000152	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.71e-05	0.000152	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOA1—atherosclerosis	1.71e-05	0.000152	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPA—atherosclerosis	1.65e-05	0.000147	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ESR1—atherosclerosis	1.65e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BGN—atherosclerosis	1.6e-05	0.000142	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.59e-05	0.000141	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA5—atherosclerosis	1.58e-05	0.000141	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—atherosclerosis	1.56e-05	0.000139	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.54e-05	0.000137	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.52e-05	0.000135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.51e-05	0.000134	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK3—atherosclerosis	1.49e-05	0.000133	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.49e-05	0.000133	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.49e-05	0.000132	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—INS—atherosclerosis	1.47e-05	0.000131	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.47e-05	0.000131	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL2—atherosclerosis	1.45e-05	0.000129	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1—atherosclerosis	1.43e-05	0.000127	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.36e-05	0.000121	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SERPINE1—atherosclerosis	1.35e-05	0.000121	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.32e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.31e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LIPC—atherosclerosis	1.31e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOC3—atherosclerosis	1.3e-05	0.000116	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LDLR—atherosclerosis	1.29e-05	0.000115	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOS3—atherosclerosis	1.29e-05	0.000115	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CETP—atherosclerosis	1.26e-05	0.000113	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.21e-05	0.000108	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.18e-05	0.000105	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—atherosclerosis	1.15e-05	0.000102	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.14e-05	0.000102	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—atherosclerosis	1.11e-05	9.86e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—atherosclerosis	1.09e-05	9.71e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—atherosclerosis	1.04e-05	9.23e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.03e-05	9.18e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	9.13e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.02e-05	9.07e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK8—atherosclerosis	1.01e-05	8.98e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	8.95e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—atherosclerosis	9.32e-06	8.29e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—atherosclerosis	9.23e-06	8.21e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK3—atherosclerosis	8.81e-06	7.84e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—atherosclerosis	8.75e-06	7.78e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TGFB1—atherosclerosis	8.55e-06	7.61e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOB—atherosclerosis	8.38e-06	7.45e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.15e-06	7.25e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—LPL—atherosclerosis	8e-06	7.12e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—atherosclerosis	7.8e-06	6.94e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CD36—atherosclerosis	7.6e-06	6.76e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.2e-06	6.41e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARA—atherosclerosis	7.07e-06	6.29e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AGT—atherosclerosis	6.84e-06	6.09e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—atherosclerosis	6.71e-06	5.97e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAV1—atherosclerosis	6.64e-06	5.91e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA1—atherosclerosis	6.63e-06	5.9e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—atherosclerosis	6.44e-06	5.73e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.05e-06	5.38e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—atherosclerosis	5.95e-06	5.29e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPARG—atherosclerosis	5.84e-06	5.2e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—INS—atherosclerosis	5.73e-06	5.1e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—atherosclerosis	5.25e-06	4.67e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NOS3—atherosclerosis	5.02e-06	4.47e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.59e-06	4.09e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—atherosclerosis	2.31e-06	2.05e-05	CbGpPWpGaD
